Global Smart Pills Technology Market Growth, Trends and Forecasts (2017 - 2022)

The global smart pills technology market is expected to reach USD XX million by 2021, growing at a CAGR of 18.51% from 2016 to 2021. The smart pills technology is a technique used for the preparation of prescription pills, drug delivery systems, diagnosis, and patient monitoring. This technology is revolutionizing the diagnosis of gastrointestinal disorders such as colorectal cancers, constipation, and gastroparesis.

The smart pill is a wireless capsule that can be swallowed, and with the help of a receiver (worn by patients) and software that analyzes the pictures captured by the smart pill, the physician is effectively able to examine the gastrointestinal tract. The gastrointestinal disorders are very common but recently, there have been increasing the incidence of colorectal cancer, inflammatory bowel disease, and Crohndisease as well. According to the US Center for disease control and prevention, in 2012, 134,784 people were diagnosed with colorectal cancer and 51,516 people died of colorectal cancer. This depicts the disease burden in the USA, and a similar trend is followed globally. The global smart pills technology market is expected to have a rapid growth in the near future. Increasing patient/physician preference for this advanced technology which tracks bodily functions and forewarn potential illness is also going to boost the growth of the market.

Global Smart Pills Technology Market- Market Dynamics

The report details various driving and restraining factors for the global smart pills technology market. Some of these are listed below.


Increasing prevalence of gastrointestinal disorders

Increasing patient preference for minimally invasive devices

Favorable reimbursement policies in USA and Japan

Technological advancement

Aging population

Increasing patient/ physician preference


Increasing cost with technological advancements

Ethical constraints

The global smart pills market has been segmented based on type into the patient monitoring device, drug delivery system, capsule endoscopy, and diagnostics. Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and South America.

The segmentation on North America discusses different market trends, and market size of smart pills in the USA, Canada, and Mexico. The Europe segment has been further subdivided into the UK, France, Germany, Benelux, and Scandinavia. The segmentation on Asia-Pacific has been subdivided into China, Japan, India, Australia and New Zealand. The Middle East & North Africa segment includes GCC, Israel, and others. The South America region includes Brazil, Argentina, and rest of Latin America. The US has the largest market share globally, followed by Europe. In the emerging markets, this technology is still in the nascent stages.

Some of the key players in the market are:

GE Healthcare

Given Imaging


Novartis AG

Olympus Medical Technology

Philips Healthcare

What the Report Offers

Market definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the smart pills technology market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the smart pills technology market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

1. Introduction

1.1 Study deliverables

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and Forecast period years

1.6 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric Forecast Model

2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry trends

5.1 Current Market Scenario

5.2 Smart Pills Technology Applications

5.3 Technology Overview

5.4 New Developments

5.5 Industry Value chain analysis

5.6 Product Lifecycle analysis

5.7 Product Benchmarking

5.8 Investment Analysis

5.9 Porter's Five Forces

5.9.1 Bargaining Power of Suppliers

5.9.2 Bargaining Power of Consumers

5.9.3 Threat to new entrants

5.9.4 Threat to substitute products and services

5.9.5 Competitive Rivalry within the industry

6. Drivers, Restraints, Opportunities, and challenges Analysis

6.1 Market Drivers

6.1.1 Increasing preference for minimally invasive device

6.1.2 Increasing incidence of gastrointestinal disorders

6.1.3 Favorable reimbursement policies in US, Japan

6.1.4 Aging population

6.1.5 Technological Advancement

6.1.6 Track bodily functions and forewarn of potential illness

6.2 Market Restraints

6.2.1 Increasing cost with technological advancement

6.2.2 Ethical constraints

7. Global Smart Pills Technology Market segmentation

7.1 Introduction

7.2 Segmentation by Patient monitoring device

7.2.1 Introduction

7.2.2 Technological overview and Market trends

7.2.3 Market size and forecast

7.3 Segmentation by Drug delivery system

7.3.1 Introduction

7.3.2 Technological overview and Market trends

7.3.3 Market size and forecast

7.4 Segmentation by Capsule endoscopy

7.4.1 Introduction

7.4.2 Technological overview and Market trends

7.4.3 Market size and forecast

7.5 Segmentation by Diagnostics

7.5.1 Introduction

7.5.2 Technological overview and Market trends

7.5.3 Market size and forecast

8. Market segmentation by Geography

8.1 North America

8.1.1 Introduction

8.1.2 United States

8.1.3 Canada

8.1.4 Mexico

8.2 Europe

8.2.1 Introduction

8.2.2 Germany

8.2.3 United Kingdom

8.2.4 France

8.2.5 Scandinavia


8.2.7 Rest of Europe

8.3 Asia-Pacific (APAC)

8.3.1 Introduction

8.3.2 China

8.3.3 Japan

8.3.4 India

8.3.5 Australia and New Zealand

8.3.6 Rest of Asia-Pacific

8.4 Middle East and North Africa

8.4.1 Introduction

8.4.2 GCC

8.4.3 Israel

8.4.4 Rest of Middle East & Africa

8.5 South America

8.5.1 Introduction

8.5.2 Brazil

8.5.3 Argentina

8.5.4 Rest of Latin America

9. Competitive Landscape

9.1 Merger and acquisition analysis

9.2 New Product Launches

9.3 Agreements, Collaborations, and Partnerships

10. Key Vendor Analysis

10.1 Novartis AG

10.2 Philips Healthcare

10.3 Medtronic

10.4 Olympus Medical Technology

10.5 GE Healthcare

10.6 Given Imaging

10.7 Proteus

10.8 Boston Scientific Corporation

10.9 Smart Pill Inc.

10.10 Medimetrics

11. Analyst outlook for Investment opportunities

12. Future Outlook of the market

Content are not available

Choose License Type